These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 3842264)

  • 1. Membrane testosterone binding sites in prostate carcinoma as a potential new marker and therapeutic target: study in paraffin tissue sections.
    Dambaki C; Kogia C; Kampa M; Darivianaki K; Nomikos M; Anezinis P; Theodoropoulos PA; Castanas E; Stathopoulos EN
    BMC Cancer; 2005 Nov; 5():148. PubMed ID: 16293185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical assay for androgen receptors in prostate cancer: a prospective study of 63 cases with long-term follow-up.
    Pertschuk LP; Macchia RJ; Feldman JG; Brady KA; Levine M; Kim DS; Eisenberg KB; Rainford E; Prins GS; Greene GL
    Ann Surg Oncol; 1994 Nov; 1(6):495-503. PubMed ID: 7531602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of estrogen, androgen and progestogen receptors in the management of carcinoma of the prostate.
    Young JD; Sidh SM; Bashirelahi N
    Trans Am Assoc Genitourin Surg; 1979; 71():23-5. PubMed ID: 545809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Predictive value of the determination of receptors in carcinoma of the prostate].
    Castellanos JM; Galán A; Calvo MA; Schwartz S
    Rev Esp Oncol; 1984; 31(2):265-77. PubMed ID: 6085864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between androgen and estrogen receptors and clinico-morphological characteristics of prostatic cancer].
    Bassalyk LS; Petrova AS; Ermilova VD; Sokolova VK; Kushlinskiĭ NE
    Arkh Patol; 1983; 45(2):23-8. PubMed ID: 6847409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery.
    Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Cheng L; Bostwick DG
    J Urol; 1999 Apr; 161(4):1233-7. PubMed ID: 10081876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen binding in prostatic carcinoma by histochemistry: update 1985.
    Pertschuk LP; Macchia RJ
    Appl Pathol; 1985; 3(4):221-9. PubMed ID: 3842264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human prostate steroid hormone receptor quantitation. Current methodology and possible utility as a clinical discriminant in carcinoma.
    Shain SA; Boesel RW
    Invest Urol; 1978 Nov; 16(3):169-74. PubMed ID: 361632
    [No Abstract]   [Full Text] [Related]  

  • 9. Androgen receptor assays in advanced prostatic cancer.
    Buttyan R; Olsson CA
    Urol Clin North Am; 1984 May; 11(2):311-7. PubMed ID: 6375068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid receptors in prostate cancer tissues and cells: pathophysiology, problems in methodology, clinical value and controversial questions.
    Pavone-Macaluso M; Carruba G; Castagnetta L
    Arch Esp Urol; 1994 Mar; 47(2):189-201. PubMed ID: 8002681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The application of steroid receptor assay in human prostate cancer research and clinical management (review).
    Ekman P
    Anticancer Res; 1982; 2(3):163-72. PubMed ID: 6751210
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.